Effect of Using Triclosan-Impregnated Polyglactin Suture to Prevent Infection of Saphenectomy Wounds in CABG: A Prospective, Double-Blind, Randomized Clinical Trial
Effect of Using Triclosan-Impregnated Polyglactin Suture to Prevent Infection of Saphenectomy Wounds in CABG: A Prospective, Double-Blind, Randomized Clinical Trial
dc.contributor.author | Santos Filho, Paulo Samuel | |
dc.contributor.author | Santos, Marisa | |
dc.contributor.author | Colafranceschi, Alexandre Siciliano | |
dc.contributor.author | Pragana, Andrea Nunes de Souza | |
dc.contributor.author | Correia, Marcelo Goulart | |
dc.contributor.author | Simões, Heloisa Helena | |
dc.contributor.author | Rocha, Fernando Alves | |
dc.contributor.author | Soggia, Maria Eduarda de Vasconcelos | |
dc.contributor.author | Santos, Ana Paula Malta Samuel | |
dc.contributor.author | Coutinho, Annie de Azeredo | |
dc.contributor.author | Figueira, Matheus Swarovsky | |
dc.contributor.author | Tura, Bernardo Rangel | |
dc.date.accessioned | 2022-08-04T17:55:00Z | |
dc.date.available | 2022-08-04T17:55:00Z | |
dc.date.issued | 2019 | |
dc.description.abstract | Objective: To evaluate the efficacy of triclosan-coated suture for the reduction of infection in saphenectomy wounds of patients undergoing coronary artery bypass graft (CABG) surgery.Methods: A total of 508 patients who underwent saphenectomy in CABG surgery were included in a prospective, randomized, double-blind trial from February/2011 to June/2014. Patients were randomized into the triclosan-coated suture group (n= 251) and the conventional non-antibiotic suture group (n=257). Demographic (gender and age), clinical (body mass index, diabetes, and use of analgesics), and intraoperative (cardiopulmonary bypass and cross-clamp times) variables and those related to the saphenectomy wound (pain, dehiscence, erythema, infection, necrosis, and hyperthermia) were measured and analyzed.Results: Of the 508 patients who underwent saphenectomy, 69.9% were males and 40.2% were diabetic. Thirty-three (6.5%) patients presented infection: 13 (5.3%) with triclosan and 20 (7.9%) with conventional suture (P=0.281). Among diabetic patients (n=204), triclosan suture was used in 45.1% with four cases of infection; conventional suture was used in 54.9% of them, with 11 cases of infection. Most patients (94.3%) underwent on-pump CABG. Wound pain was observed in 9.9% of patients with triclosan-coated suture and in 17.9% with conventional suture (P=0.011). Wound hyperthermia was found in 1.6% of patients with triclosan-coated suture and in 5.4% of those with conventional suture (P=0.028).Conclusion: Triclosan-coated suture shows lower infection rate in saphenectomy of patients undergoing CABG, although the differences were not statistically significant. Pain and wound hyperthermia were less frequent in patients with triclosan-coated sutures compared with conventional sutures. | en |
dc.identifier.citation | Santos PS Filho, Santos M, Colafranceschi AS, Pragana ANS, Correia MG, Simões HH, Rocha FA, Soggia MEV, Santos APMS, Coutinho AA, Figueira MS, Tura BR. Effect of Using Triclosan-Impregnated Polyglactin Suture to Prevent Infection of Saphenectomy Wounds in CABG: A Prospective, Double-Blind, Randomized Clinical Trial. Braz J Cardiovasc Surg. 2019 Dec 1;34(5):588-595. | |
dc.identifier.uri | https://dspace.inc.saude.gov.br/handle/123456789/55 | |
dc.language.iso | en | |
dc.publisher | Brazilian journal of Cardiovascular Surgery | |
dc.subject | Wound Infection | en |
dc.subject | Sutures | en |
dc.subject | Triclosan | en |
dc.subject | Coronary Artery Bypass Graft | en |
dc.subject | Cardiopulmonary Bypass | en |
dc.subject | Erythema | en |
dc.subject | Body Mass Index | en |
dc.subject | Analgesics | en |
dc.subject | Pain | en |
dc.subject.mesh | Triclosan / therapeutic use | en |
dc.subject.mesh | Treatment Outcome | en |
dc.subject.mesh | Time Factors | en |
dc.subject.mesh | Suture Techniques | en |
dc.subject.mesh | Surgical Wound Infection / prevention & control | en |
dc.subject.mesh | Statistics, Nonparametric | en |
dc.subject.mesh | Saphenous Vein / surgery | en |
dc.subject.mesh | Reproducibility of Results | en |
dc.subject.mesh | Prospective Studies | en |
dc.subject.mesh | Polyglactin 910 / therapeutic use | en |
dc.subject.mesh | Pain, Postoperative / prevention & control | en |
dc.subject.mesh | Middle Aged | en |
dc.subject.mesh | Male | en |
dc.subject.mesh | Humans | en |
dc.subject.mesh | Female | en |
dc.subject.mesh | Double-Blind Method | en |
dc.subject.mesh | Diabetes Complications | en |
dc.subject.mesh | Coronary Artery Bypass / methods | en |
dc.subject.mesh | Coronary Artery Bypass / adverse effects | en |
dc.subject.mesh | Body Mass Index | en |
dc.subject.mesh | Anti-Infective Agents, Local / therapeutic use | en |
dc.subject.mesh | Aged, 80 and over | en |
dc.subject.mesh | Aged | en |
dc.subject.mesh | Adult | en |
dc.title | Effect of Using Triclosan-Impregnated Polyglactin Suture to Prevent Infection of Saphenectomy Wounds in CABG: A Prospective, Double-Blind, Randomized Clinical Trial | en |
dc.type | Article |